Does ROPIVACAINE Cause Hyperthermia malignant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hyperthermia malignant have been filed in association with ROPIVACAINE (Ropivacaine Hydrochloride). This represents 0.2% of all adverse event reports for ROPIVACAINE.
5
Reports of Hyperthermia malignant with ROPIVACAINE
0.2%
of all ROPIVACAINE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Hyperthermia malignant From ROPIVACAINE?
Of the 5 reports, 3 (60.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Hyperthermia malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROPIVACAINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ROPIVACAINE Cause?
Vomiting (483)
Dyspnoea (458)
Drug hypersensitivity (448)
Oedema (446)
Pneumonia (445)
Asthma (430)
Wheezing (418)
Drug ineffective (262)
Pain (187)
Hypotension (178)
What Other Drugs Cause Hyperthermia malignant?
SUCCINYLCHOLINE (276)
SEVOFLURANE (207)
PROPOFOL (205)
FORANE (170)
ROCURONIUM (114)
FENTANYL (107)
SEVOFLURANE, USP (93)
ISOFLURANE (87)
MIDAZOLAM (62)
CISATRACURIUM (60)
Which ROPIVACAINE Alternatives Have Lower Hyperthermia malignant Risk?
ROPIVACAINE vs ROSIGLITAZONE
ROPIVACAINE vs ROSUVASTATIN
ROPIVACAINE vs ROSUVASTATIN\ROSUVASTATIN
ROPIVACAINE vs ROTIGOTINE
ROPIVACAINE vs ROXADUSTAT